发明名称 INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF
摘要 <p>A compound represented by the general formula (I) of the present invention, which has an EP 1 receptor antagonism: [wherein A represents a benzene ring or the like; Y represents a C 1-6 alkylene group or the like; R N represents a hydrogen atom or a C 1-6 alkyl group; R 1 represents a hydrogen atom, a C 1-6 alkyl group or the like; R 2 represents a phenyl group which may have a substituent, a 5-membered aromatic heterocyclic group which may have a substituent, a 6-membered aromatic heterocyclic group which may have a substituent or the like;R 3 represents a halogen atom, a C 1-6 alkoxy group or the like; R 4 represents a hydrogen atom or the like; and R 5 represents a hydrogen atom or the like] or a pharmaceutically acceptable salt thereof is provided. Furthermore, the compound (I) of the present invention can be used as an agent for treating or preventing LUTS, in particular, various symptoms of OABs.</p>
申请公布号 EP2474530(B1) 申请公布日期 2014.09.03
申请号 EP20100804369 申请日期 2010.07.26
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 KONDO, TATSUHIRO;KONDO, ATSUSHI;TATANI, KAZUYA;KAWAMURA, NAOHIRO
分类号 C07D209/18;A61K31/404;A61K31/422;A61K31/427;A61K31/4439;A61P13/02;A61P43/00;C07D401/04;C07D401/06;C07D401/14;C07D405/04;C07D405/06;C07D405/14;C07D409/04;C07D409/06;C07D409/14;C07D413/14;C07D417/06;C07D417/14 主分类号 C07D209/18
代理机构 代理人
主权项
地址